| Title: | Genetic variants that influence incidence, biological factors and clinical outcomes of sepsis and septic shock. |
| Lead Institution: | University of British Columbia |
| Principal investigator: | Dr Keith Walley |
Application 51283
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Infections are the most common cause of death worldwide and no significant improvements in the treatment of severe infection have been developed since the discovery of antibiotics almost a century ago. The role that genetics play in severe infections has not previously been widely investigated. Sepsis is an illness where the patient's tissues and organs are damaged by the body's own immune response to infection, and is often life-threatening. Sepsis can lead to septic shock when blood pressure drops and fluid replacement does not improve the condition. The aim of this project is to explore various ways genetics contributes to sepsis and septic shock. Some of the questions we will be exploring include: - Do genetic variants associated with cholesterol affect survival of sepsis and septic shock patients? - Do there exist different types of sepsis and septic shock patients, and if so, how do genetics play a role in differentiating these patients? - What are some other genetic variants that affect survival of sepsis and septic shock patients? Findings of this project could lead to new treatments for sepsis and septic shock and reduce the death toll caused by these illnesses2 Publications
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 19738 | Obesity- and Lipid-Related Traits May Causally Contribute to Sepsis-Associated Acute Kidney Injury | Kyle R. Campbell (+5) | 2025 | Critical Care Medicine |
| 19382 | Plasma apolipoprotein A-I is a causal protective factor in sepsis | Kyle R. Campbell (+9) | 2025 | Scientific Reports |
Enabling scientific discoveries that improve human health